Liquid chromatography–tandem mass spectrometry (LC–MS–MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma
- 1 December 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 829 (1-2), 75-81
- https://doi.org/10.1016/j.jchromb.2005.09.034
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- On-line capillary electrophoresis-electrospray mass spectrometry for the stereoselective analysis of drugs and metabolitesElectrophoresis, 2001
- Use of vancomycin silica stationary phase in packed capillary electrochromatography: II. Enantiomer separation of venlafaxine and O-desmethylvenlafaxine in human plasmaJournal of Chromatography A, 2001
- Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolitesElectrophoresis, 2001
- Use of vancomycin silica stationary phase in packed capillary electrochromatography I. Enantiomer separation of basic compoundsElectrophoresis, 2001
- Simultaneous stereoselective analysis of venlafaxine and O-desmethylvenlafaxine enantiomers in clinical samples by capillary electrophoresis using charged cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Enantioseparation of venlafaxine andO-desmethylvenlafaxine by capillary electrophoresis with mixed cyclodextrinsChromatographia, 1999
- Biochemical, neurophysiological, and behavioral effects of Wy‐45,233 and other identified metabolites of the antidepressant venlafaxineDrug Development Research, 1991
- AntidepressantsDrugs, 1989
- Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivativeBiochemical Pharmacology, 1986
- DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activityEuropean Journal of Pharmacology, 1985